Xponance Inc. Has $245,000 Stock Position in Integer Holdings Co. (NYSE:ITGR)

Xponance Inc. grew its holdings in Integer Holdings Co. (NYSE:ITGR) by 4.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,112 shares of the medical equipment provider’s stock after purchasing an additional 99 shares during the period. Xponance Inc.’s holdings in Integer were worth $245,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in ITGR. Quest Partners LLC increased its stake in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 142 shares in the last quarter. Headlands Technologies LLC bought a new position in shares of Integer in the 1st quarter valued at about $106,000. Innealta Capital LLC bought a new stake in Integer during the second quarter worth about $110,000. Finally, Hancock Whitney Corp acquired a new position in Integer during the first quarter valued at approximately $203,000. Institutional investors own 99.29% of the company’s stock.

Insider Activity at Integer

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

ITGR has been the topic of several recent analyst reports. Bank of America boosted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday. Truist Financial boosted their target price on shares of Integer from $137.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday. Benchmark reiterated a “buy” rating and issued a $130.00 price target on shares of Integer in a research note on Wednesday. Citigroup boosted their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Oppenheimer began coverage on shares of Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price for the company. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $137.29.

Integer Price Performance

Shares of ITGR opened at $127.23 on Thursday. The company’s 50-day moving average is $123.43 and its 200-day moving average is $119.37. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market capitalization of $4.26 billion, a PE ratio of 44.02, a PEG ratio of 1.87 and a beta of 1.09. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $131.87.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. During the same period in the prior year, the firm earned $1.14 EPS. The business’s revenue was up 9.0% on a year-over-year basis. Equities analysts forecast that Integer Holdings Co. will post 5.31 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.